L1CAM and neuroblastoma: Recently, children diagnosed with refractory neuroblastoma were treated with L1CAM-targeting CAR T cells harboring the 4-1BB co-stimulatory domain in a clinical phase I trial (NCT02311621, Available online: https:clinicaltrials.gov (accessed on 1 March 2021)).